Marc Ullman commented on the NutraIngredientsUSA article, “FTC charges The Bountiful Company for ‘review hijacking’ on Amazon.”

“Review hijacking ‘seems like a legitimate issue,'” said Ullman. “What you’re dealing with is not just changing the labels, but the doses, and more. It’s really a different product and that’s a problem both for consumers and competitors.”

Please join us on February 9 as Partner Bob Hussar and Associates Ashley Algazi and Mary Connolly present on OMIG’s finalized regulations.

On December 28th, the Office of Medicaid Inspector General (OMIG) released their FINAL compliance and self-disclosure regulations. The regulations implement 2020 changes to OMIG’s statutory authority to implement and oversee:

• mandatory provider

Marc S. Ullman, of counsel to Rivkin Radler, is a new columnist for Natural Products Insider magazine. Named “Oral Arguments by Marc Ullman,” the quarterly column will opine on regulatory and compliance actions by government entities that affect the dietary supplement, health food, nutraceutical and cosmeceutical industries.

A longtime industry observer and often-quoted source for

Rivkin Radler is delighted to announce that it has elevated eight attorneys to partners, effective January 1.

The new partners are Jennifer Abreu, Christina M. Bezas, Kaitlyn E. Flynn, Daniel E. Furshpan, Bernadette Kasnicki, Marie A. Landsman, Siobhain P. Minarovich and Avi Sinensky.

“These eight attorneys embody the best attributes of Rivkin Radler – astute

Marc Ullman was quoted in Natural Products Insider’s article, “Analysis: CBD food industry unlikely to placate FDA.” The article discusses recent FDA warning letters sent to companies who were found to be illegal selling food and beverage products that contain CBD.

Ullman expresses concern with the how these companies are marketing these products if they

Marc Ullman was cited in the NutraIngredientsUSA article, “FDA’s takedown of NMN raises fairness transparency concerns.”

The FDA has disallowed the anti-aging ingredient, NMN, and this has raised questions of fairness and transparency.

Ullman said the current FDA interpretation sets up a situation in which a pharma company could file an IND, let the issue

Rivkin Radler is pleased to announce that the Firm has been named to the U.S. News – Best Lawyers “Best Law Firms” list for 2023. The Firm was ranked in the following regions and practice areas:

Metropolitan Tier 1

Albany: Commercial Litigation, Health Care Law

Long Island: Elder Law, Health Care Law, Insurance Law, Litigation-Health Care,

Marc Ullman was quoted in the NutraIngredientsUSA article, titled “DOJ prohibits Arizona company from distributing adulterated or misbranded supplements.”

Ullman discussed a federal court’s recent ban on Arizona based company, Global Vitality Inc. The company repeatedly violated the Federal Food, Drug and Cosmetics Act over the last decade, by selling “adulterated and misbranded dietary

Marc Ullman spoke with Natural Products INSIDER for the article “Ullman to moderate discussion at SupplySide West regulatory session”

SupplySide West brings together more than 18,000 ingredient buyers and suppliers from the dietary supplement, beverage, functional food, personal care and sports nutrition industries. This year’s conference will be held at the Mandalay Bay Resort & Casino in

Marc Ullman was quoted in the NutraIngredientsUSA article, “Amazon warning over skin tag products puts online giant on notice for assuring regulatory compliance.”

The article explains that the FDA issued a warning letter to Amazon for two marketers whose products are sold on Amazon’s site. These products claim to remove skin tags, but are not